BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/31/2021 12:21:18 PM | Browse: 374 | Download: 378
 |
Received |
|
2021-04-10 17:12 |
|
Peer-Review Started |
|
2021-04-10 17:16 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-06-24 18:31 |
|
Revised |
|
2021-07-16 12:02 |
|
Second Decision |
|
2021-12-17 03:24 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-12-22 23:32 |
|
Articles in Press |
|
2021-12-22 23:32 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-12-06 15:05 |
|
Typeset the Manuscript |
|
2021-12-29 14:49 |
|
Publish the Manuscript Online |
|
2021-12-31 12:21 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Transfusion-transmitted hepatitis E: What we know so far?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Carmen Ka Man Cheung, Sunny Hei Wong, Alvin Wing Hin Law and Man Fai Law |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Man Fai Law, MRCP, Doctor, Medicine and Therapeutics, Prince of Wales Hospital, 30-32 Ngai Shing Street, Shatin, Hong Kong 852, China. mflaw99@yahoo.com.hk |
| Key Words |
Hepatitis E virus; Acute and chronic hepatitis; Immunosuppression; Blood transfusion; Transplantation |
| Core Tip |
Transfusion-transmitted hepatitis E virus (HEV) is an emerging global health concern. In immunocompromised patients, chronic HEV infection increases the risk of liver cirrhosis. The prevalence of viremia and anti-HEV immunoglobulin G in asymptomatic blood donors varies widely between countries but even low concentrations of HEV in blood components are infectious, and in most countries blood donations are not routinely screened for HEV. Treatment of persistent infection includes modification of the immunosuppressant regimen followed by ribavirin. The need for screening of HEV in all blood donations remains controversial. Strategies to reduce de novo HEV infection should also be emphasized. |
| Publish Date |
2021-12-31 12:21 |
| Citation |
Cheung CKM, Wong SH, Law AWH, Law MF. Transfusion-transmitted hepatitis E: What we know so far? World J Gastroenterol 2022; 28(1): 47-75 |
| URL |
https://www.wjgnet.com/1007-9327/full/v28/i1/47.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v28.i1.47 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
